The two faces of IL-6 on Th1/Th2 differentiation

Molecular Immunology

Volumn 39, Issue 9, 2002, Pages 531-536

  Diehl, Sean ^a   Rincón, Mercedes ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokine signaling; Interleukin; Th1 Th2 differentiation

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; PROTEIN; SUPRESSOR OF CYTOKINE SIGNALING 1 PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; EFFECTOR CELL; GENE EXPRESSION; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; TRANSCRIPTION INITIATION;

EID: 0036889996     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(02)00210-9     Document Type: Review

References (45)

1. Akira S., Issihiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., Nakajima T., Hirano T., Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9:1990;1897-1906.
2. Akira S., Nishio Y., Inoue M., Wang X.J., Wei S., Matsusaka T., Yoshida K., Sudo T., Naruto M., Kishimoto T. Molecular cloning of APRF a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell. 77:1994;63-71.
3. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handman E., Sprigg N.S., Corbin J.E., Cornish A.L., Darwiche R., Owczarek C.M., Kay T.W., Nicola N.A., Hertzog P.J., Metcalf D., Hilton D.J. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell. 98:1999a;597-608.
4. Alexander W.S., Starr R., Metcalf D., Nicholson S.E., Farley A., Elefanty A.G., Brysha M., Kile B.T., Richardson R., Baca M., Zhang J.G., Willson T.A., Viney E.M., Sprigg N.S., Rakar S., Corbin J., Mifsud S., DiRago L., Cary D., Nicola N.A., Hilton D.J. Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction. J. Leukoc. Biol. 66:1999b;588-592.
5. Anguita J., Persing D., Rincón M., Barthold S.W., Fikrig E. Effect of anti-interleukin 12 treatment on murine Lyme borreliosis. J. Clinic. Invest. 97:1996;1028-1034.
6. Anguita J., Rincón M., Samanta S., Barthold S.W., Flavell R.A., Fikrig E. Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased Lyme arthritis. J. Infect. Dis. 178:1997;1512-1515.
7. Bach E.A., Aguet M., Schreiber R.D. The IFNγ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:1997;563-591.
8. Bradley L.M., Dalton D.K., Croft M. A direct role for IFNγ in regulation of Th1 cell development. J. Immunol. 157:1996;1350-1358.
9. -/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease. Immunology. 104:2001;92-98.
10. Chow C.-W., Rincón M., Davis R.J. Requirement for transcription factor NFAT in interleukin-2 expression. Mol. Cell. Biol. 19:1999;2300-2307.
11. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:1997;297-322.
12. Daeipour M., Kumar G., Amaral M.C., Nel A.E. Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF-10. J. Immunol. 150:1993;4743-4753.
13. Diehl S., Anguita J., Hoffmeyer A., Zapton T., Ihle J.N., Fikrig E., Rincón M. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity. 13:2000;805-815.
14. Diehl S., Chow C.W., Weiss L., Palmetshofer A., Twardzik T., Rounds L., Serfling E., Davis R.J., Anguita J., Rincon M. Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation. J. Exp. Med. 196:2002;39-49.
15. Endo T.A., Masura M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 387:1997;921-924.
16. Hirano T. Interleukin 6 and its receptor: 10 years later. Int. Rev. Immunol. 16:1998;249-284.
17. + T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:1993;547-549.
18. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature. 341:1989;746-749.
19. Keane-Myers A., Nickell S.P. Role of IL-4 and IFNγ in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 155:1995;2020-2028.
20. Kinoshita S., Akira S., Kishimoto T. A member of the C/EBP family, NF-IL6β, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1473-1476.
21. Le Gros G., Ben-Sasson S.Z., Seder R., Finkelman F.D., Paul W.E. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. J. Exp. Med. 172:1990;921-929.
22. Leonard W.J., O'Shea J.J. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:1998;293-322.
23. Lutticken C., Wegenka U.M., Yuan J., Buschmann J., Schindler C., Ziemiecki A., Harpur A.G., Wilks A.F., Yasukawa K., Taga T., Kismimoto T., Barbieri G., Pellegrini S., Sendtner M., Heinrich P.C., Horn F. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science. 263:1994;89-92.
24. Marine J.C., Topham D.J., McKay C., Wang D., Parganas E., Stravopodis D., Yoshimura A., Ihle J.N. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell. 98:1999;609-616.
25. Matyniak J.E., Reiner S.L. T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 181:1995;1251-1254.
26. Murphy K.M., Ouyang W., Farrar J.D., Yang J., Ranganath S., Asnagli H., Afkarian M., Murphy T.L. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18:2000;451-594.
27. Naka T., Fujimoto M., Kishimoto T. Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. Trends Biochem. Sci. 24:1999;394-398.
28. Naka T., Matsumoto T., Narazaki M., Fujimoto M., Morita Y., Ohsawa Y., Saito H., Nagasawa T., Uchiyama Y., Kishimoto T. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95:1998;15577-15582.
29. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature. 387:1997;924-929.
30. Nakajima K., Matsuda T., Fujitani Y., Kojima H., Yamanaka Y., Nakae K., Takeda T., Hirano T. Signal transduction through IL-6 receptor: involvement of multiple protein kinases, stat factors, and a novel H7-sensitive pathway. Ann N.Y. Acad. Sci. 762:1995;55-70.
31. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19:2001;423-474.
32. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:1998;275-283.
33. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 273:1998;29279-29282.
34. Poli V., Mancini F.P., Cortese R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell. 63:1990;643-653.
35. Ramji D.P., Vitelli A., Tronche F., Cortese R., Ciliberto G. The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6β, are induced by IL-6 to promote acute phase gene transcription via different mechanisms. Nucleic Acids Res. 21:1993;289-294.
36. + T cells. J. Exp. Med. 185:1997;461-469.
37. Rincón M., Flavell R.A. Transcriptional control of Th1/Th2 polarization. Curr. Biol. 7:1997;R729-R732.
38. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1992;1091-1098.
39. + T cells to enhance priming for IFNγ production and diminish IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10188-10192.
40. Stahl N., Boulton T.G., Farruggella T., Ip N.Y., Davis S., Witthuhn B.A., Quelle F.W., Silvennoinen O., Barbieri G., Pellegrini S., Ihle J.N., Yancopoulos G.D. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6β receptor components. Science. 263:1994;92-95.
41. Starr R., Metcalf D., Elefanty A.G., Brysha M., Willson T.A., Nicola N.A., Hilton D.J., Alexander W.S. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. U.S.A. 95:1998;14395-14399.
42. Starr R., Willson T.A., Viney E., Murray L.J.L., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., Hilton D.J. A family of cytokine-inducible inhibitors of signaling. Nature. 387:1997;917-921.
43. Swain S.L., Weinberg A.D., English M., Huston G. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:1990;3796-3806.
44. Swain S.L. Who does the polarizing? Curr. Biol. 5:1995;849-851.
45. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6-triggers the association of its receptor with a possible signal transducer, gp130. Cell. 58:1989;573-581.